AffirmXH

What AffirmXH does

AffirmXH is a medical device and digital health startup founded in 2020 and based in Austin, Texas, focused on continuous biometric monitoring and programmable digital treatment programs for healthcare providers, researchers, and patients. The company's core product is a disposable Continuous Temperature Sensor patch that captures more than 50 temperature readings per hour without requiring maintenance or recharging, connecting to a mobile phone or cellular hub. Layered on top of this hardware is a No-Code Digital Treatment Builder, a drag-and-drop platform that allows non-engineers to configure treatment workflows, run data collection and algorithm development, and integrate with apps, texts, and emails. Built-in templates cover eight therapeutic verticals: oncology, maternity, diabetes, sickle cell disease, cardiac care, adherence, clinical trials, and research.

The technology architecture was conceived around a four-level feedback loop framework that progresses from establishing baseline loops to increasing accuracy through additional variables, accelerating velocity through population analysis using machine learning, and ultimately personalizing responses via AI. The platform was designed as an open ecosystem spanning devices, algorithms, and data, intended to serve multiple stakeholder types (doctors, researchers, parents) across multiple deployment contexts.

Commercially, AffirmXH operated as a private Delaware C-corporation with 1-10 employees and pursued a subscription/recurring revenue model around its platform and devices, though pricing was not publicly disclosed. The company filed an SEC Form D exempt offering in June 2021 targeting $1.8 million for working capital, with approximately $305,000 sold at the time of filing. In 2023, AffirmXH was acquired by Life365, a strategic operating company in remote health solutions, ending its independent operations and folding its technology into Life365's broader portfolio.

Name

AffirmXH

Legal name

AFFIRMXH INC.

Website

https://affirmxh.com

Company type

Private

Founded year

2020

Operating status

Acquired

Headcount range

1–10 employees

Short description

AffirmXH is an Austin-based medical device startup (founded 2020, now a Life365 subsidiary) that built a disposable continuous temperature sensor patch and a no-code digital treatment builder for healthcare providers, researchers, and patients across eight therapeutic verticals.

Ownership category

akta.pro rank

Product category

Remote Patient Monitoring Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro industry

PRIMARYHLAHACAK

Continuous Temperature & Fever Monitoring (Wearable Thermometry)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

SECONDARYHLACAPAI

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)

Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

SECONDARYHLALAFAA

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)

Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

SECONDARYHSABALAI

Remote Adherence Monitoring & Smart Dispenser Services

Home & Personal Services/Elder Care & In-Home Care Services/Medication Management & In-Home Pharmacy Support

Keywords

• Continuous biometric monitoring
• Digital treatment platform
• Remote patient monitoring
• Wearable temperature sensor
• No-code health builder

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Digital Health Platform: The company appears to generate revenue through its digital health platform and continuous monitoring devices. The focus on wellness and self-management digital treatments suggests a subscription or device-based model. However, specific revenue model details are not publicly disclosed.

Go-to-market motion1 record

Core offering

AffirmXH provides a continuous biometric monitoring platform combining a disposable patch temperature sensor with a no-code digital treatment builder. The sensor delivers 50+ temperature readings per hour without maintenance or recharging, while the drag-and-drop treatment builder allows non-engineers to configure data collection, algorithms, and system integrations. Built-in templates accelerate deployment for oncology, maternity, diabetes, sickle cell disease, cardiac, adherence, clinical trial, and research use cases.

Product overview

AffirmXH offers a health monitoring platform centered on its Continuous Temperature Sensor — a disposable patch device providing 50+ temperature readings per hour. The platform is complemented by a No-Code Digital Treatment Builder that enables non-engineers to create programmable treatments for data collection and algorithm development. The company has been acquired by Life365. The system supports multiple health monitoring use cases including Oncology, Maternity, Diabetes, Sickle Cell Disease, Cardiac conditions, Adherence tracking, Clinical Trials, and Research applications, with information delivered via apps, texts, and emails.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 50+ temperature readings per hour

Segments8 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

One partnership is on record.

• Life365coreStrategic or Co-development Partner · 8 June 2021Life365 announced the strategic acquisition of AffirmXH to enhance its health solutions portfolio. The acquisition brings AffirmXH's continuous temperature sensor technology and no-code digital treatment builder into the Life365 ecosystem. This represents a strategic acquisition rather than a traditional partnership, with Life365 integrating AffirmXH's technology to strengthen its position in the biometric monitoring and digital health treatment space.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• VivaLNK: VivaLNK makes continuous wearable vital sign monitoring patches, including temperature, ECG, and heart rate sensors used in clinical and remote patient monitoring applications. Directly comparable to AffirmXH's disposable patch approach for continuous biometric monitoring in healthcare.
• BioIntellisense: BioIntellisense produces the BioSticker and BioButton continuous wearable monitoring devices for clinical-grade vital signs including temperature, respiratory rate, and heart rate. Direct competitor in the disposable/multi-day continuous vital sign monitoring category.
• VitalConnect: VitalConnect offers the VistaPatch and VitalPatch continuous biosensors used for multi-parameter remote patient monitoring including temperature and cardiac metrics. Comparable medical-grade wearable platform targeting hospital and remote monitoring use cases.
• Empatica: Empatica develops wearable health monitoring devices (EpiMonitor, Embrace) for continuous physiological monitoring across clinical trials, neurology, and research applications. Comparable continuous wearable biometric platform with FDA-cleared products.

Broad incumbents

• Life365: Life365 is the parent company that acquired AffirmXH in 2023. As a remote patient monitoring platform operator with broader connected health solutions, Life365 is both parent and the most direct commercial extension of AffirmXH's biometric monitoring capabilities.
• Oura: Oura Ring provides continuous wearable health monitoring including skin temperature, heart rate, and sleep metrics. A broader wearable health player with overlapping continuous temperature monitoring capabilities and a much larger consumer base.
• Apple (Health/Apple Watch): Apple Watch includes continuous health monitoring features such as skin temperature sensing, heart rate, and ECG, with a dominant consumer footprint. Broad incumbent that competes in the continuous wearable health monitoring category.

Emerging players

• iHealth Labs: iHealth Labs offers consumer and clinical-grade connected health devices including continuous temperature monitors and other vital sign devices. Comparable continuous biometric monitoring with consumer and clinical positioning.
• Tempdrop: Tempdrop is a wearable continuous temperature monitoring device primarily for fertility tracking and wellness. Comparable disposable/wearable overnight temperature sensing with consumer health positioning.
• CareBand: CareBand produces wearable continuous location and physiological monitoring devices for senior care and clinical settings. Comparable wearable continuous monitoring positioning in elder care and patient monitoring segments.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/affirmxh

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AffirmXH